Motion Stimulation Therapy Market Analysis by Functional Neuromuscular Therapy and Deep Brain Therapy Through 2024 to 2034

<p><strong>Motion stimulation therapy market</strong> is projected to reach USD 1.4 billion by 2024. A CAGR of 3.8% is estimated between 2024 and 2034. Towards the end of 2034, the market is predicted to reach USD 2 billion.</p><table> <tbody> <tr> <th scope='row'>Attributes</th> <td>Key Insights</td> </tr> <tr> <th scope='row'>Historical Size, 2023</th> <td>USD 1.3 billion</td> </tr> <tr> <th scope='row'>Estimated Size, 2024</th> <td>USD 1.4 billion</td> </tr> <tr> <th scope='row'>Projected Size, 2034</th> <td>USD 2 billion</td> </tr> <tr> <th scope='row'>Value-based CAGR (2024 to 2034)</th> <td>3.8%</td> </tr> </tbody></table><p>Semi Annual Industry Update</p><table> <tbody> <tr> <th scope='row'>Particular</th> <td>Value CAGR</td> </tr> <tr> <th scope='row'>H1</th> <td>4.8% (2023 to 2033)</td> </tr> <tr> <th scope='row'>H2</th> <td>4.5% (2023 to 2033)</td> </tr> <tr> <th scope='row'>H1</th> <td>3.8% (2024 to 2034)</td> </tr> <tr> <th scope='row'>H2</th> <td>3.4% (2024 to 2034)</td> </tr> </tbody></table><p>Country-wise Insights</p><table> <tbody> <tr> <th scope='row'>Countries</th> <td>Value CAGR (2024 to 2034)</td> </tr> <tr> <th scope='row'>United States</th> <td>1.1%</td> </tr> <tr> <th scope='row'>Canada</th> <td>1.9%</td> </tr> <tr> <th scope='row'>United Kingdom</th> <td>1.4%</td> </tr> <tr> <th scope='row'>Germany</th> <td>1.2%</td> </tr> <tr> <th scope='row'>India</th> <td>4.6%</td> </tr> <tr> <th scope='row'>China</th> <td>4.4%</td> </tr> <tr> <th scope='row'>South Korea</th> <td>3.5%</td> </tr> </tbody></table><p>Category-wise Insights</p><table> <tbody> <tr> <th scope='row'>Therapy</th> <td>Functional Neuromuscular Therapy</td> </tr> <tr> <th scope='row'>Value Share (2023)</th> <td>37.15%</td> </tr> </tbody></table><table> <tbody> <tr> <th scope='row'>End User</th> <td>Hospitals</td> </tr> <tr> <th scope='row'>Value Share (2023)</th> <td>45.7%</td> </tr> </tbody></table>

<p><strong>动态刺激疗法市场规模预计将于2024年达到14亿美元。</strong>预计在2024年至2034年期间，该市场的复合年增长率将达到3.8%。至2034年末，市场规模预计将达到20亿美元。</p><table> <tbody> <tr> <th scope='row'>属性</th> <td>关键洞察</td> </tr> <tr> <th scope='row'>历史规模，2023年</th> <td>13亿美元</td> </tr> <tr> <th scope='row'>估计规模，2024年</th> <td>14亿美元</td> </tr> <tr> <th scope='row'>预测规模，2034年</th> <td>20亿美元</td> </tr> <tr> <th scope='row'>基于价值的CAGR（2024年至2034年）</th> <td>3.8%</td> </tr> </tbody></table><p>半年度行业更新</p><table> <tbody> <tr> <th scope='row'>特定</th> <td>价值CAGR</td> </tr> <tr> <th scope='row'>上半年</th> <td>4.8%（2023年至2033年）</td> </tr> <tr> <th scope='row'>下半年</th> <td>4.5%（2023年至2033年）</td> </tr> <tr> <th scope='row'>上半年</th> <td>3.8%（2024年至2034年）</td> </tr> <tr> <th scope='row'>下半年</th> <td>3.4%（2024年至2034年）</td> </tr> </tbody></table><p>按国家洞察</p><table> <tbody> <tr> <th scope='row'>国家</th> <td>价值CAGR（2024年至2034年）</td> </tr> <tr> <th scope='row'>美国</th> <td>1.1%</td> </tr> <tr> <th scope='row'>加拿大</th> <td>1.9%</td> </tr> <tr> <th scope='row'>英国</th> <td>1.4%</td> </tr> <tr> <th scope='row'>德国</th> <td>1.2%</td> </tr> <tr> <th scope='row'>印度</th> <td>4.6%</td> </tr> <tr> <th scope='row'>中国</th> <td>4.4%</td> </tr> <tr> <th scope='row'>韩国</th> <td>3.5%</td> </tr> </tbody></table><p>按类别洞察</p><table> <tbody> <tr> <th scope='row'>疗法</th> <td>功能性神经肌肉疗法</td> </tr> <tr> <th scope='row'>价值份额（2023年）</th> <td>37.15%</td> </tr> </tbody></table><table> <tbody> <tr> <th scope='row'>最终用户</th> <td>医院</td> </tr> <tr> <th scope='row'>价值份额（2023年）</th> <td>45.7%</td> </tr> </tbody></table>